Coalition for the Reversal of Breast Cancer Mortality in African American Women

A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond

Showing posts with label Hsp90 inhibitor. Show all posts
Showing posts with label Hsp90 inhibitor. Show all posts
Saturday, March 9, 2013

Synta announces results from Ganetespib Phase 2b trial on NSCLC

›
Published on September 29, 2012 at 5:14 AM   Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today ann...
›
Home
View web version

Steering Committee

Peggy Kankonde
View my complete profile
Powered by Blogger.